Connect Biopharma Holdings Limited
Connect Biopharma Holdings Limited (CNTB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CNTB · as of Jun 8, 2026
Key Statistics
Explore Connect Biopharma Holdings Limited Data
cntb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 80.0%
The CNTB analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +129.36% upside from the current price of $2.18.
Competitors & Peers
cntb competitorsCNTB
ARTV
CNTX
IFRX
IMA
KLRSStock Performance
Full HistoryAbout Connect Biopharma Holdings Limited
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious au…
what is connect biopharma holdings limited · cntb stock overview · connect biopharma holdings limited company profile · who is connect biopharma holdings limited ceo · cntb NASDAQ · connect biopharma holdings limited headquarters · connect biopharma holdings limited business segments
About Stock Overview & Key Data
Connect Biopharma Holdings Limited (CNTB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 19, 2021. As of the latest trading session, CNTB stock price is $2.18, with a market capitalization of $138.5M. The stock has returned +181.69% over the past 12 months and -21.99% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Connect Biopharma Holdings Limited stock is Buy, with an average 12-month price target of $5.00. In fiscal year 2025, Connect Biopharma Holdings Limited reported revenue of $64000.00 and net income of -$55.5M. For detailed data — including Connect Biopharma Holdings Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Connect Biopharma Holdings Limited (CNTB) stock price is $2.18. The stock is traded on NASDAQ under the ticker symbol CNTB. The 52-week range is $0.75 – $3.82.